Description
UNDERSTANDING SEMA
Semaglutide is a medication and GLP-1 (Glucagon-Like Peptide-1) receptor agonist that has gained attention for its effectiveness in managing type 2 diabetes and supporting weight loss. Through its ability to regulate blood sugar levels, appetite, and metabolism, Semaglutide is revolutionising approaches to metabolic health and obesity management. Semaglutide works by activating GLP-1 receptors in the pancreas, brain, and gastrointestinal tract, helping regulate insulin secretion, glucagon release, and appetite.
Semaglutide helps the body control blood sugar and energy balance through several mechanisms:
1. Pancreas: Increases insulin secretion when blood glucose is high and reduces glucagon release.
2. Brain: Signals satiety, helping reduce appetite and caloric intake.
3. Stomach: Slows gastric emptying, preventing spikes in post-meal glucose.
4. Metabolism: Supports improved glucose utilisation and weight management.
BENEFITS:
1. Blood Sugar Control
Semaglutide improves glycemic control, helping people with type 2 diabetes achieve better HbA1c levels and reduce hyperglycemia.
2. Weight Loss
Demonstrates significant weight reduction, with users losing up to 15-20% of body weight over several months when combined with lifestyle changes.
3. Cardiovascular Benefits
Research indicates that Semaglutide reduces the risk of cardiovascular events in individuals with type 2 diabetes and overweight.
4. Appetite and Satiety Regulation
By acting on brain GLP-1 receptors, Semaglutide reduces hunger and cravings, making it easier to maintain a caloric deficit for weight management.
5. Improved Metabolic Health
Semaglutide supports insulin sensitivity, lipid metabolism, and overall metabolic function, contributing to better long-term health outcomes.
ADMINISTRATION:
Use for subcutaneous injection only
DOSAGE RECOMMENDATION:
Week 1-4 | 0.25mg once a week
Week 5-8 | 0.5mg once a week
Week 9-12 | 1mg once a week
Week 13-16 | 1.7mg once a week
From week 17 | 2.4mg once a week
(15 clicks – 1mg)






